DSIJ Mindshare

COVID-19 vaccine of Zydus Cadila gets nod to initiate human clinical trials

DSIJ Intelligence 0 2023 Article rating: 4.9

The vaccine candidate ZyCov-D has been developed originally at the company’s research centre-Vaccine Technology Centre (VTC) in Ahmedabad, India. The vaccine when tested on animals brings out a strong immune response in multiple animal species like mice, rats, guinea pigs and rabbits. 

RSS
First4445464749515253Last
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR